Diagonal Bio AB announces the outcome of the exercise of warrants of series TO 1
On September 26, 2024, the exercise period for Diagonal Bio AB's ("Diagonal" or the "Company") warrants of series TO 1 ("TO 1") ended. A total of 77.794 warrants of series TO 1 have been exercised to subscribe for 77.794 shares, corresponding to gross proceeds of SEK 3.889,70.During the exercise period from and including September 12, 2024, up to and including September 26, 2024, holders of warrants of series TO 1 have had the right to subscribe for one (1) new share in Diagonal for each warrant of series TO 1 at a price of SEK 0,05 per share. A total of 77.794 warrants of series TO 1 have
Read original
Teollisuuden Voima Oyj´s (TVO) Olkiluoto 2 (OL2) plant unit will return to electricity production on October 6th, following the installation of a spare generator rotor. The OL2 generator rotor sustained damage in early September, and the root cause of the issue is still under investigation.Electricity production at OL2 will initially resume at a reduced capacity of 725 MW, down from its full output of 890 MW. Because the root cause of the rotor damage is still unclear, the unit will stay on reduced power level to limit the risk of failure. This period is expected to take several months.
